NCT06303193
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Refractory, +7 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Anemia, Refractory
Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.
191 public trials
36 recruiting studies
Anemia, Refractory trial results
Recruiting
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
NCT03383575
- Conditions
- Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +22 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Cleveland Clinic Foundation Cleveland, Ohio, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT07025824
- Conditions
- AML - Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +11 more
- Locations
-
- Medizinische Fakultät der TU Dresden, Medizinische Klinik und Poliklinik I Dresden, Germany
- Universitätsklinikum Münster, Medizinische Klinik A, KMT-Zentrum Münster, Germany
- Universitätsklinikum Aachen, Medizinische Klinik IV Aachen, Germany
- Klinikum Augsburg, Medizinische Klinik II Augsburg, Germany
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- The University of Alabama at Birmingham Birmingham, Alabama, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT01861106
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +9 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hemolytic, +11 more
- Locations
-
- University of Maryland, Baltimore (UMB) Baltimore, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07761533
- Conditions
- Acute Myeloid Leukemia (AML), Anemia, Anemia, Refractory, +11 more
- Locations
-
- The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Recruiting
Personalized NK Cell Therapy in CBT
NCT02727803
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03128034
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +34 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03670966
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, +37 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States